Family Office ClubEvents
Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com
Menu
DirectoryAll firmsBrowse by countryBrowse by cityBrowse by where they investBrowse by parent industryBrowse by stageMost activeLargest disclosed fundsResearchCompanies backed by the most CVCsMost active corporate investorsFund size ladderDeals per quarterFor FoundersFor Corporate VCsAboutTalk to a humanTell me your situationText (808) 600-9260

MEDIPAL Innovation Fund

Corporate venture profile

Parent Medipal HoldingsHQ Tokyo, JapanFounded 2021

MEDIPAL Innovation Fund is the corporate venture arm of Medipal Holdings, a healthcare company. It was founded in 2021 and is based in Tokyo, Japan. Sectors it names: healthcare and digital health, biotech and life sciences.

Every figure links to its source

Where it invests

Geography

Headquarters
Tokyo, Japan

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyMedipal Holdings (7459)Single sourceS1
Parent industryHealthcare and life sciencesSingle sourceS1
Founded2021Single sourceS2
HeadquartersTokyo, JapanSingle sourceS1
StatusActiveSingle sourceS2
Capital sourceParent company onlySingle sourceS1

About Medipal Holdings

ItemDetailSource
Listed as7459S1
HeadquartersJapanS1

Fund vehicles

VehicleSizeYearSource
MEDIPAL Innovation Investment LPSNot published2021S2

History

  1. Third-party allotment subscribed by the fund (25 February)S1
  2. Third-party allotment subscribed by the fund (30 September)S2

Portfolio

Portfolio companies named in public sources: Metagen Therapeutics, mutex.S1

Shared portfolio with other corporate VCs

1 companies on the MEDIPAL Innovation Fund portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
Canon Marketing Japan MIRAI Fund1Metagen Therapeutics
Dentsu Ventures1Metagen Therapeutics
Tokai Tokyo Investment1Metagen Therapeutics

Companies backed by the most corporate VCs

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Medipal Holdings press release: investment in Metagen Therapeutics via MEDIPAL Innovation fundFirm
  2. S2Medipal Holdings press release: investment in mutex via MEDIPAL Innovation fundFirm

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by MEDIPAL Innovation Fund or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.

Report a correction